Roche to Introduce its Next-Generation Portfolio of SARS-CoV-2 Rapid Antigen Tests (“2.0”) Under CE Mark for Self-Test and Professional Use
Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® Pass, Roche’s… Read More



